Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
3776
DELISTED
Mersana Therapeutics
MRSN
| $86.3K | ﹤0.01% |
1,826
+4
| +0.2% | +$176 |
|
|
OKUR
3777
OnKure Therapeutics
OKUR
$154M
| $84.7K | ﹤0.01% |
+4,982
| New | +$73.7K |
|
3778
Scholar Rock
SRRK
$5.67B
| $84K | ﹤0.01% |
10,485
-370,540
| -97% | -$3.25M |
|
3779
Heritage Global
HGBL
$40.3M
| $84K | ﹤0.01% |
49,399
-57,199
| -54% | -$117K |
|
3780
1stdibs.com
DIBS
$149M
| $82.8K | ﹤0.01% |
18,767
-1,656
| -8% | -$7.47K |
|
3781
iQIYI
IQ
$1.23B
| $82.2K | ﹤0.01% |
28,728
-4,930
| -15% | -$14.3K |
|
|
PGRE
3782
DELISTED
Paramount Group
PGRE
| $81.9K | ﹤0.01% |
16,649
+293
| +2% | +$1.45K |
|
3783
Direct Digital Holdings
DRCT
$1.89M
| $80.7K | ﹤0.01% |
174
| – | – |
|
3784
Kodiak Sciences
KOD
$2.6B
| $79.9K | ﹤0.01% |
30,628
-3,000
| -9% | -$7.97K |
|
|
RVNC
3785
DELISTED
Revance Therapeutics, Inc.
RVNC
| $79.8K | ﹤0.01% |
15,380
-152,568
| -91% | -$758K |
|
3786
Aurinia Pharmaceuticals
AUPH
$1.91B
| $79.3K | ﹤0.01% |
10,815
+130
| +1% | +$806 |
|
3787
Santander
BSBR
$42.5B
| $79.3K | ﹤0.01% |
15,068
-8,568
| -36% | -$45.6K |
|
|
STKL
3788
DELISTED
SunOpta
STKL
| $78.8K | ﹤0.01% |
12,350
-35
| -0.3% | -$205 |
|
|
SJT
3789
San Juan Basin Royalty Trust
SJT
$117M
| $77.6K | ﹤0.01% |
+20,964
| New | +$78.4K |
|
3790
Veritone
VERI
$101M
| $76.4K | ﹤0.01% |
21,280
| – | – |
|
3791
EVgo
EVGO
$223M
| $71.7K | ﹤0.01% |
+17,310
| New | +$66.2K |
|
3792
Copel
ELPC
$8.71B
| $71.5K | ﹤0.01% |
11,444
-215
| -2% | -$1.42K |
|
|
AHT
3793
Ashford Hospitality Trust
AHT
$20.9M
| $69.8K | ﹤0.01% |
9,325
-13
| -0.1% | -$122 |
|
3794
Gabelli Equity Trust
GAB
$1.75B
| $68.9K | ﹤0.01% |
+12,551
| New | +$67.8K |
|
3795
Aldeyra Therapeutics
ALDX
$92.9M
| $67.8K | ﹤0.01% |
+12,580
| New | +$59.9K |
|
3796
Seer Inc
SEER
$122M
| $67.5K | ﹤0.01% |
34,256
-327,545
| -91% | -$574K |
|
3797
Archer Aviation
ACHR
$3.54B
| $67.4K | ﹤0.01% |
22,241
+2,025
| +10% | +$7.74K |
|
3798
C4 Therapeutics
CCCC
$385M
| $66.2K | ﹤0.01% |
+11,620
| New | +$69.9K |
|
3799
Coherus Oncology
CHRS
$217M
| $63.9K | ﹤0.01% |
61,449
| – | – |
|
3800
Ambev
ABEV
$48.1B
| $60.4K | ﹤0.01% |
24,765
-23,898
| -49% | -$53.6K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.